Rockin' with IsoGuardian
|
ALBANY, N.Y. — February 28, 2026
IsoGuardian, Inc., a medical device company based in Albany, New York, announced the completion of a clinical pilot study at Albany Medical Center evaluating its FDA-registered reusable Level 2 isolation gown. Conducted across inpatient and procedural outpatient units, the study found strong positive results and marks a formal institutional validation milestone for the company, signaling institutional readiness.
Pilot was facilitated in conjunction with Albany Medical College’s Office of Translational Research, Innovation, and Technology Transfer (OTR) with 3rd party principal investigators. Evaluations took place over the course of 2 weeks in 4 departments in Albany Medical Center. A total of 116 daily surveys and 41 end-of-week surveys were collected from participating clinicians.
Left: Stephanie Dosiek and Sara Rudin
Photo courtesy of Albany Medical Center.
Results
Daily survey responses indicated:
- Protective — 95% positive
- Easy to use — 91% positive
- Comfortable — 85% positive
Clinicians described the gown as “comfortable/stylish/high quality,” noted that it “feels more protective,” and highlighted its “fully encompassing” coverage compared to standard gowns.
Albany Med Health System’s release of results can be found at: https://www.albanymed.org/news/pilot-study-tests-isolation-gowns-in-collaboration-with-colleges-business-incubator/The article further noted that “conversations are ongoing about the potential use of the gowns on a larger scale at Albany Medical Center.”